Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Subscribe to Curetis Newsletter
Curetis Publishes Business and Financial Update for the First Quarter 2018
Curetis to Hold Annual General Shareholders’ Meeting on June 21, 2018
ATS - American Thoracic Society 2018 - San Diego, USA - May 20 to 22, 2018
ASM - Microbe 2018 - Alanta, USA - June 8 to 10, 2018